[go: up one dir, main page]

CN110736779B - 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法 - Google Patents

用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法 Download PDF

Info

Publication number
CN110736779B
CN110736779B CN201911078972.1A CN201911078972A CN110736779B CN 110736779 B CN110736779 B CN 110736779B CN 201911078972 A CN201911078972 A CN 201911078972A CN 110736779 B CN110736779 B CN 110736779B
Authority
CN
China
Prior art keywords
zif
bpnss
self
electrode
exosomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201911078972.1A
Other languages
English (en)
Other versions
CN110736779A (zh
Inventor
桂日军
孙玉娇
金辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao University
Original Assignee
Qingdao University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao University filed Critical Qingdao University
Priority to CN201911078972.1A priority Critical patent/CN110736779B/zh
Priority to US17/051,782 priority patent/US11105767B1/en
Priority to PCT/CN2019/116519 priority patent/WO2021087945A1/zh
Publication of CN110736779A publication Critical patent/CN110736779A/zh
Application granted granted Critical
Publication of CN110736779B publication Critical patent/CN110736779B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/31—Half-cells with permeable membranes, e.g. semi-porous or perm-selective membranes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3277—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a redox reaction, e.g. detection by cyclic voltammetry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3278—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction involving nanosized elements, e.g. nanogaps or nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/4163—Systems checking the operation of, or calibrating, the measuring apparatus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Composite Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法，基于黑磷纳米片BPNSs、适体和二茂铁Fc掺杂钴基金属有机骨架ZIF‑67复合物在氧化铟锡ITO电极上简易自组装，构建双功能杂化薄膜即适体‑BPNSs/Fc/ZIF‑67/ITO。亚甲基蓝MB标记的适体与CD63蛋白特异性结合，实现精准的蛋白俘获。该蛋白是乳腺癌MCF‑7细胞外泌体携带的特定生物分子，实现对该肿瘤细胞外泌体的检测。以MB为响应信号，Fc为参比，构建肿瘤外泌体定量检测的自校准传感器。与现有技术相比，本发明操作便捷、灵敏度高、成本低、特异性好，可作为一种新的外泌体自校准检测方法，用于生物医学样品中外泌体的定量检测。

Description

用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法
技术领域：
本发明属于功能杂化薄膜材料和肿瘤外泌体传感器的制备技术领域，具体涉及一种基于黑磷纳米片和二茂铁掺杂的钴基金属有机骨架复合物自组装的双功能杂化薄膜材料的制备方法，其制备的薄膜材料可用于CD63跨膜蛋白的精准俘获和乳腺癌外泌体的自校准检测。
背景技术：
外泌体是通过內溶体途径从多囊体中释放的尺寸为50～100纳米的细胞外囊泡，它从亲本细胞中携带了大量生物高分子，包括跨膜和胞质蛋白、mRNA、DNA和micro-RNA等。外泌体充当着介导细胞间信息的信使，在探测疾病尤其癌症相关的生理状态改变方面发挥了重要作用。近年来，外泌体作为一种有前景的生物标志物被广泛用于癌症的早期诊断，克服了癌症检测过程存在侵入式筛选的高成本和低敏感度的问题。当前，大量的文献资料报道了外泌体的定量检测，但现有的检测技术依然存在某些挑战，难以实现纳米级外泌体的直接和特异性分析。例如，流式细胞术检测受限于较弱的光散射，粒子追踪方法缺乏特异性。在疾病早期阶段，外泌体浓度较低，需要开发新的方法实现外泌体的高敏感检测。
当前用于外泌体检测的方法主要包括流式细胞术、纳米颗粒追踪分析、表面等离子共振、比色、发光和电化学分析等。例如，Zhu等采用表面等离子共振成像技术实现了对外泌体的定量检测(Ling Zhu,Kun Wang,Jian Cui,Huan Liu,Xiangli Bu,Huailei Ma,Weizhi Wang,He Gong,Christopher Lausted,Leroy Hood,Guang Yang,Zhiyuan Hu,Label-free quantitative detection of tumor-derived exosomes through surfaceplasmon resonance imaging,Analytical Chemistry,2014,86,8857-8864)；Xia等基于DNA包封单臂碳纳米管构建了比色检测外泌体的方法(Yaokun Xia,Mengmeng Liu,Liangliang Wang,An Yan,Wenhui He,Mei Chen,Jianming Lan,Jiaoxing Xu,LunhuiGuan,Jinghua Chen,A visible and colorimetric aptasensor based on DNA-cappedsingle-walled carbon nanotubes for detection of exosomes,Biosensors andBioelectronics,2017,92,8–15)。李智洋等利用G-四连体-Hemin模拟过氧化酶催化H2O2反应产生信号，结合滚环扩增合成大量G-四连体进行信号放大，以实现外泌体的定量检测(李智洋,何农跃,黄蓉蓉.专利名称:一种基于适配体与滚环扩增的外泌体检测方法.国家发明专利.公开号:CN109655512A)；王国胜开发了集外泌体分离纯化和特异性外泌体半定量检测的一种产品，构建了基于外泌体的体外即时检测平台(王国胜.一种基于外泌体的体外即时检测平台及其检测方法.国家发明专利.公开号:CN108872564A)。
尽管有关外泌体定量检测的工作已有国内外文献和专利报道，但实现对纳米外泌体的直接和特异性、高灵敏及低成本的高效检测，依然是当前亟待解决的重要科学问题之一。基于此，本发明公开了一种基于黑磷纳米片BPNSs和二茂铁Fc掺杂的钴基金属有机骨架ZIF-67复合物在氧化铟锡ITO薄膜电极上简易自组装的双功能杂化薄膜材料BPNSs/Fc/ZIF-67的制备方法，该薄膜材料可用于CD63跨膜蛋白的精准俘获和乳腺癌MCF-7细胞外泌体的自校准检测。截止本专利申请提交之日为止，尚未检索到有关BPNSs/Fc/ZIF-67双功能杂化薄膜材料的制备，以及基于该薄膜材料用于肿瘤外泌体自校准检测的国内外文献和专利报道。
发明内容：
本发明的目的在于克服上述现有技术存在的问题，设计一种操作便捷、灵敏度高、成本较低、特异性好的肿瘤外泌体检测新方法。
为实现上述目的，本发明涉及的一种用于肿瘤外泌体自校准检测的双功能杂化薄膜，其制备方法包括以下步骤：
1.用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法，其特征在于，该方法具体包括以下步骤：
(1)Fc/ZIF-67复合物的制备：称取一定量的Co(NO3)2·6H2O和2-甲基咪唑，放置于47mL乙醇和3mL去离子水的混合溶剂中，磁力搅拌下形成均匀的混合液，Co(NO3)2·6H2O和2-甲基咪唑的浓度分别调节至0.1～0.5mol/L和0.8～1.5mol/L。将此混合液加入电解槽中，以Ag/AgCl为参比电极，铂丝为对电极，氧化铟锡ITO为工作电极，以-5至-10V恒定电压，循环伏安扫描100～500s，将Fc/ZIF-67复合物电沉积在氧化铟锡ITO电极表面。
(2)BPNSs/Fc/ZIF-67复合物的制备：称取10～30mg黑磷晶体加入50mL的1-甲基-2-吡咯烷酮中，在超声波清洗机中超声1～6h后，转入探头式超声波发生器中超声1～4h，产物分散液在12000rpm下离心15min，取上层分散液在5000rpm下离心15min。将制得的BPNSs分散液，逐滴添加至Fc/ZIF-67复合物表面，自然干燥，在氧化铟锡ITO电极表面制得BPNSs/Fc/ZIF-67复合物。
(3)适体-BPNSs/Fc/ZIF-67杂化薄膜的制备：将BPNSs/Fc/ZIF-67/ITO薄膜电极浸没在含有1～10μM的CD63跨膜蛋白对应单链DNA适体的磷酸盐水缓冲液中，在37℃下孵育30～120min，取出该薄膜电极，自然干燥，在氧化铟锡ITO电极表面制得适体BPNSs/Fc/ZIF-67复合物，即制得适体-BPNSs/Fc/ZIF-67杂化薄膜。
(4)杂化薄膜传感器的制备：以杂化薄膜为工作电极，置于电化学工作站的三电极体系中，以磷酸盐水缓冲液为电解液，加入从乳腺癌MCF-7细胞提取的外泌体，测定不同外泌体浓度下的电化学方波伏安曲线。以修饰在适体链上的亚甲基蓝MB为响应信号，掺杂在ZIF-67金属有机骨架内的二茂铁Fc为参比信号，以电流峰强度IFc/IMB比值为自校准信号输出，拟合IFc/IMB比值与外泌体浓度之间的线性关系，构建用于外泌体定量检测的自校准传感器。其中，肿瘤外泌体浓度的线性检测范围为1×102～1×106particlesμL–1，检测限为50～100particlesμL–1。
本发明的效果是：报道了一种基于黑磷纳米片BPNSs、适体和二茂铁Fc掺杂钴基金属有机骨架ZIF-67复合物，在氧化铟锡ITO薄膜电极上简易自组装的双功能杂化薄膜材料，即适体-BPNSs/Fc/ZIF-67/ITO。亚甲基蓝MB标记的单链DNA适体与CD63跨膜蛋白发生适-配体特异性结合，实现对CD63跨膜蛋白的精准俘获。CD63跨膜蛋白是乳腺癌MCF-7细胞外泌体携带的特定生物高分子，可作为生物标志物，实现对乳腺癌MCF-7细胞外泌体的检测。以MB为响应信号，掺杂在ZIF-67内的二茂铁Fc为参比信号，以电流峰强度IFc/IMB比值为自校准信号输出，拟合IFc/IMB与外泌体浓度间的线性关系，构建用于肿瘤外泌体定量检测的自校准传感器。与现有技术相比，本发明方法操作便捷、灵敏度高、成本较低、特异性好，可作为一种新的外泌体自校准检测方法，用于生物医学样品中外泌体的定量检测。
附图说明：
图1为基于黑磷纳米片和二茂铁掺杂的钴基金属有机骨架复合物自组装的双功能杂化薄膜材料的制备，及其用于CD63跨膜蛋白的精准俘获和乳腺癌外泌体自校准检测的原理示意图；
图2(a)为不同外泌体浓度存在下，以该杂化薄膜材料为工作电极测定的电化学方波伏安曲线；
图2(b)为不同外泌体浓度对应的二茂铁和亚甲基蓝的氧化还原电流峰强度比值IFc/IMB，拟合不同IFc/IMB比值与外泌体浓度之间的线性关系。
具体实施方式：
下面结合附图并通过具体实施例对本发明进行详细说明。
实施例1：
本实施例涉及的基于黑磷纳米片和二茂铁掺杂的钴基金属有机骨架复合物自组装的双功能杂化薄膜材料，其制备方法和检测原理的示意图如图1所示，具体制备步骤如下：
Fc/ZIF-67复合物的制备：称取一定量Co(NO3)2·6H2O和2-甲基咪唑放置47mL乙醇和3mL去离子水的混合溶剂中，磁力搅拌形成均匀的混合液，Co(NO3)2·6H2O和2-甲基咪唑的浓度分别调节至0.1mol/L和0.8mol/L。将此混合液加入电解槽中，以Ag/AgCl为参比电极，铂丝为对电极，氧化铟锡ITO为工作电极，以-5V恒定电压，循环伏安扫描100s，将Fc/ZIF-67复合物电沉积在氧化铟锡ITO电极表面。
BPNSs/Fc/ZIF-67复合物的制备：称取10mg黑磷晶体加入50mL的1-甲基-2-吡咯烷酮中，在超声波清洗机中超声1h后，转入探头式超声波发生器中超声1h，产物分散液在12000rpm下离心15min，取上层分散液在5000rpm下离心15min。将制得的BPNSs分散液，逐滴添加至Fc/ZIF-67复合物表面，自然干燥，在氧化铟锡ITO电极表面制得BPNSs/Fc/ZIF-67复合物。
适体-BPNSs/Fc/ZIF-67杂化薄膜的制备：将BPNSs/Fc/ZIF-67/ITO薄膜电极浸没在含有1μM的CD63跨膜蛋白对应单链DNA适体的磷酸盐水缓冲液中，在37℃下孵育30min，取出该薄膜电极，自然干燥，在氧化铟锡ITO电极表面制得适体BPNSs/Fc/ZIF-67复合物，即制得适体-BPNSs/Fc/ZIF-67杂化薄膜。
杂化薄膜传感器的制备：以杂化薄膜为工作电极，置于电化学工作站的三电极体系中，以磷酸盐水缓冲液为电解液，加入从乳腺癌MCF-7细胞提取的外泌体，测定不同外泌体浓度下的电化学方波伏安曲线(如图2a所示)。以修饰在适体链上的亚甲基蓝MB为响应信号，掺杂在ZIF-67金属有机骨架内的二茂铁Fc为参比信号，以电流峰强度IFc/IMB比值为自校准信号输出，拟合IFc/IMB比值与外泌体浓度之间的线性关系(如图2b所示)，构建用于外泌体定量检测的自校准传感器。肿瘤外泌体浓度线性检测范围1.3×102～2.6×105particlesμL–1，检测限60particlesμL–1。
实施例2：
本实施例涉及的基于黑磷纳米片和二茂铁掺杂的钴基金属有机骨架复合物自组装的双功能杂化薄膜材料，其制备方法和检测原理同实施例1，其它具体制备步骤如下：
Fc/ZIF-67复合物的制备：称取一定量Co(NO3)2·6H2O和2-甲基咪唑放置47mL乙醇和3mL去离子水的混合溶剂中，磁力搅拌形成均匀的混合液，Co(NO3)2·6H2O和2-甲基咪唑的浓度分别调节至0.3mol/L和1.2mol/L。将此混合液加入电解槽中，以Ag/AgCl为参比电极，铂丝为对电极，氧化铟锡ITO为工作电极，以-8V恒定电压，循环伏安扫描200s，将Fc/ZIF-67复合物电沉积在氧化铟锡ITO电极表面。
BPNSs/Fc/ZIF-67复合物的制备：称取20mg黑磷晶体加入50mL的1-甲基-2-吡咯烷酮中，在超声波清洗机中超声3h后，转入探头式超声波发生器中超声2h，产物分散液在12000rpm下离心15min，取上层分散液在5000rpm下离心15min。将制得的BPNSs分散液，逐滴添加至Fc/ZIF-67复合物表面，自然干燥，在氧化铟锡ITO电极表面制得BPNSs/Fc/ZIF-67复合物。
适体-BPNSs/Fc/ZIF-67杂化薄膜的制备：将BPNSs/Fc/ZIF-67/ITO薄膜电极浸没在含有4μM的CD63跨膜蛋白对应单链DNA适体的磷酸盐水缓冲液中，在37℃下孵育50min，取出该薄膜电极，自然干燥，在氧化铟锡ITO电极表面制得适体BPNSs/Fc/ZIF-67复合物，即制得适体-BPNSs/Fc/ZIF-67杂化薄膜。
杂化薄膜传感器的制备：以杂化薄膜为工作电极，置于电化学工作站的三电极体系中，以磷酸盐水缓冲液为电解液，加入从乳腺癌MCF-7细胞提取的外泌体，测定不同外泌体浓度下的电化学方波伏安曲线。以修饰在适体链上的亚甲基蓝MB为响应信号，掺杂在ZIF-67金属有机骨架内的二茂铁Fc为参比信号，以电流峰强度IFc/IMB比值为自校准信号输出，拟合IFc/IMB比值与外泌体浓度之间的线性关系，构建用于外泌体定量检测的自校准传感器。肿瘤外泌体浓度线性检测范围1.0×102～1.0×105particles μL–1，检测限50particles μL–1。
实施例3：
本实施例涉及的基于黑磷纳米片和二茂铁掺杂的钴基金属有机骨架复合物自组装的双功能杂化薄膜材料，其制备方法和检测原理同实施例1，其它具体制备步骤如下：
Fc/ZIF-67复合物的制备：称取一定量Co(NO3)2·6H2O和2-甲基咪唑放置47mL乙醇和3mL去离子水的混合溶剂中，磁力搅拌形成均匀的混合液，Co(NO3)2·6H2O和2-甲基咪唑的浓度分别调节至0.5mol/L和1.5mol/L。将此混合液加入电解槽中，以Ag/AgCl为参比电极，铂丝为对电极，氧化铟锡ITO为工作电极，以-10V恒定电压，循环伏安扫描400s，将Fc/ZIF-67复合物电沉积在氧化铟锡ITO电极表面。
BPNSs/Fc/ZIF-67复合物的制备：称取30mg黑磷晶体加入50mL的1-甲基-2-吡咯烷酮中，在超声波清洗机中超声5h后，转入探头式超声波发生器中超声4h，产物分散液在12000rpm下离心15min，取上层分散液在5000rpm下离心15min。将制得的BPNSs分散液，逐滴添加至Fc/ZIF-67复合物表面，自然干燥，在氧化铟锡ITO电极表面制得BPNSs/Fc/ZIF-67复合物。
适体-BPNSs/Fc/ZIF-67杂化薄膜的制备：将BPNSs/Fc/ZIF-67/ITO薄膜电极浸没在含有8μM的CD63跨膜蛋白对应单链DNA适体的磷酸盐水缓冲液中，在37℃下孵育100min，取出该薄膜电极，自然干燥，在氧化铟锡ITO电极表面制得适体BPNSs/Fc/ZIF-67复合物，即制得适体-BPNSs/Fc/ZIF-67杂化薄膜。
杂化薄膜传感器的制备：以杂化薄膜为工作电极，置于电化学工作站的三电极体系中，以磷酸盐水缓冲液为电解液，加入从乳腺癌MCF-7细胞提取的外泌体，测定不同外泌体浓度下的电化学方波伏安曲线。以修饰在适体链上的亚甲基蓝MB为响应信号，掺杂在ZIF-67金属有机骨架内的二茂铁Fc为参比信号，以电流峰强度IFc/IMB比值为自校准信号输出，拟合IFc/IMB比值与外泌体浓度之间的线性关系，构建用于外泌体定量检测的自校准传感器。肿瘤外泌体浓度线性检测范围1.0×103～1.0×106particles μL–1，检测限80particles μL–1。
以上所述仅是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员，在不脱离本发明原理的前提下，还可以做出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。

Claims (1)

1.用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法，其特征在于，该方法具体包括以下步骤：
(1)二茂铁掺杂的钴基金属有机骨架Fc/ZIF-67复合物的制备：称取一定量的Co(NO3)2·6H2O和2-甲基咪唑，放置于47mL乙醇和3mL去离子水的混合溶剂中，磁力搅拌下形成均匀的混合液，Co(NO3)2·6H2O和2-甲基咪唑的浓度分别调节至0.1～0.5mol/L和0.8～1.5mol/L；将此混合液加入电解槽中，以Ag/AgCl为参比电极，铂丝为对电极，氧化铟锡ITO为工作电极，以-5至-10V恒定电压，循环伏安扫描100～500s，将Fc/ZIF-67复合物电沉积在氧化铟锡ITO电极表面；
(2)黑磷纳米片和二茂铁掺杂的钴基金属有机骨架BPNSs/Fc/ZIF-67复合物的制备：称取10～30mg黑磷晶体加入50mL的1-甲基-2-吡咯烷酮中，在超声波清洗机中超声1～6h后，转入探头式超声波发生器中超声1～4h，产物分散液在12000rpm下离心15min，取上层分散液在5000rpm下离心15min；将制得的黑磷纳米片BPNSs分散液，逐滴添加至Fc/ZIF-67复合物表面，自然干燥，在氧化铟锡ITO电极表面制得BPNSs/Fc/ZIF-67复合物；
(3)适体-BPNSs/Fc/ZIF-67杂化薄膜的制备：将BPNSs/Fc/ZIF-67/ITO薄膜电极浸没在含有1～10μM的CD63跨膜蛋白对应单链DNA适体的磷酸盐水缓冲液中，在37℃下孵育30～120min，取出该薄膜电极，自然干燥，在氧化铟锡ITO电极表面制得适体BPNSs/Fc/ZIF-67复合物，即制得适体-BPNSs/Fc/ZIF-67杂化薄膜；
(4)杂化薄膜传感器的制备：以杂化薄膜为工作电极，置于电化学工作站的三电极体系中，以磷酸盐水缓冲液为电解液，加入从乳腺癌MCF-7细胞提取的外泌体，测定不同外泌体浓度下的电化学方波伏安曲线；以修饰在适体链上的亚甲基蓝MB为响应信号，掺杂在ZIF-67金属有机骨架内的二茂铁Fc为参比信号，以电流峰强度IFc/IMB比值为自校准信号输出，拟合IFc/IMB比值与外泌体浓度之间的线性关系，构建用于外泌体定量检测的自校准传感器；其中，肿瘤外泌体浓度的线性检测范围为1×102～1×106particlesμL–1，检测限为50～100particles μL–1。
CN201911078972.1A 2019-11-07 2019-11-07 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法 Expired - Fee Related CN110736779B (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201911078972.1A CN110736779B (zh) 2019-11-07 2019-11-07 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法
US17/051,782 US11105767B1 (en) 2019-11-07 2019-11-08 Method for preparing dual-functional hybrid thin-film for self-calibration detection of tumor-derived exosomes
PCT/CN2019/116519 WO2021087945A1 (zh) 2019-11-07 2019-11-08 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911078972.1A CN110736779B (zh) 2019-11-07 2019-11-07 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法

Publications (2)

Publication Number Publication Date
CN110736779A CN110736779A (zh) 2020-01-31
CN110736779B true CN110736779B (zh) 2020-06-02

Family

ID=69272414

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911078972.1A Expired - Fee Related CN110736779B (zh) 2019-11-07 2019-11-07 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法

Country Status (3)

Country Link
US (1) US11105767B1 (zh)
CN (1) CN110736779B (zh)
WO (1) WO2021087945A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111337713B (zh) * 2020-03-11 2022-09-06 苏州大学 一种生物传感器的制备方法及外泌体检测方法
CN111366625B (zh) * 2020-05-07 2021-04-02 青岛大学 基于锌配位黑磷纳米片复合物与生物酶催化的比率电化学尿酸传感器的制备方法
CN112034172A (zh) * 2020-08-24 2020-12-04 军事科学院军事医学研究院环境医学与作业医学研究所 一种用于诺氟沙星快速检测的黑磷比色/光热双模式可视化免疫层析检测方法
CN113219180B (zh) * 2021-01-29 2022-05-13 厦门大学 一种外泌体pd-l1的研究方法
CN113567206B (zh) * 2021-07-20 2022-09-09 上海交通大学 基于金属有机骨架纳米材料的膜蛋白及膜相关蛋白提取方法
CN114113251A (zh) * 2021-11-16 2022-03-01 上海纳米技术及应用国家工程研究中心有限公司 一种稳定检测铵根离子的钴基电化学传感器的制备方法及其产品和应用
CN114561463B (zh) * 2021-12-03 2023-07-28 济南大学 一种基于滚环与杂交链式反应检测外泌体的生物传感器
CN114184662B (zh) * 2021-12-10 2023-11-03 安徽医科大学第二附属医院 一种外泌体分析用mof电化学传感器及其制备与应用
CN114295694B (zh) * 2022-01-03 2023-06-06 重庆医科大学 一种用于乳腺癌her-2检测的电化学发光适体传感器及其检测方法
CN114563456B (zh) * 2022-03-04 2024-06-14 章毅 以MOFs探针对外泌体实施电化学检测的方法
CN114894871B (zh) * 2022-05-16 2024-01-16 安徽大学 一种高灵敏度亚硝酸还原酶生物电极的制备方法及应用
CN115109268B (zh) * 2022-08-01 2023-05-23 安徽科技学院 一种高效降解土霉素光催化材料的制备方法及其应用
CN116064789B (zh) * 2022-08-09 2025-01-28 汕头大学医学院 黑磷/锰离子复合纳米传感器及其制备方法和应用
CN115582145B (zh) * 2022-09-28 2024-02-02 陕西师范大学 Zif-67填充二茂铁衍生物纳米复合燃速催化剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932815B2 (en) * 2012-04-16 2015-01-13 Biological Dynamics, Inc. Nucleic acid sample preparation
EP3377904B1 (en) * 2015-11-20 2024-05-01 Duke University Urea biosensors and uses thereof
EP3380006B1 (en) * 2015-11-29 2022-04-27 Ramot at Tel-Aviv University Ltd. Sensing electrode and method of fabricating the same
CN109133014B (zh) * 2018-06-13 2022-04-12 青岛大学 一种CoN3@N-C复合电催化剂的制备方法
CN108872564A (zh) 2018-09-12 2018-11-23 杭州多泰科技有限公司 一种基于外泌体的体外即时检测平台及其检测方法
CN109239040B (zh) * 2018-10-09 2020-12-15 太原理工大学 一种基于适体链-黑磷纳米片荧光能量共振转移的砷离子检测方法
CN109307700B (zh) * 2018-10-19 2020-12-04 海南师范大学 一种钴基金属有机框架材料/三维石墨烯纳米复合材料修饰电极测定芦丁的方法
CN109655512A (zh) 2018-12-18 2019-04-19 南京鼓楼医院 一种基于适配体与滚环扩增的外泌体检测方法
CN109529064A (zh) * 2019-01-04 2019-03-29 北京大学深圳医院 可以实现肿瘤局部定点放射治疗的黑磷微泡药物载体及其制备方法
CN109813786B (zh) * 2019-03-13 2021-11-09 郑州轻工业学院 双金属-有机骨架材料、支架材料及其制备方法，电化学免疫传感器及其制备方法、应用
CN110108881B (zh) * 2019-04-30 2022-03-22 江苏大学 一种双功能生物传感器hrp@zif-8/dna的制备方法及其应用

Also Published As

Publication number Publication date
US20210247350A1 (en) 2021-08-12
WO2021087945A1 (zh) 2021-05-14
US11105767B1 (en) 2021-08-31
CN110736779A (zh) 2020-01-31

Similar Documents

Publication Publication Date Title
CN110736779B (zh) 用于肿瘤外泌体自校准检测的双功能杂化薄膜的制备方法
CN109187693B (zh) 基于纳米复合物修饰电极的香草醛比率电化学适体传感器的制备方法
Yang et al. Au doped poly-thionine and poly-m-Cresol purple: Synthesis and their application in simultaneously electrochemical detection of two lung cancer markers CEA and CYFRA21-1
Liu et al. Functionalized graphene-based biomimetic microsensor interfacing with living cells to sensitively monitor nitric oxide release
Liu et al. Functional nanostructure-loaded three-dimensional graphene foam as a non-enzymatic electrochemical sensor for reagentless glucose detection
CN108562573B (zh) 一种基于二碳化三钛二维金属碳化物催化鲁米诺电化学发光探针的生物传感器及制备方法
CN111366625B (zh) 基于锌配位黑磷纳米片复合物与生物酶催化的比率电化学尿酸传感器的制备方法
CN105651840B (zh) 一种检测β‑淀粉样蛋白寡聚体的类免疫电化学传感器及其制备方法
CN102778561B (zh) 壳核纳米材料构建的肿瘤标志物免疫传感器的制备及应用
Zhang et al. An ultra-sensitive electrochemical aptasensor based on Co-MOF/ZIF-8 nano-thin-film by the in-situ electrochemical synthesis for simultaneous detection of multiple biomarkers of breast cancer
Yang et al. Electrochemical impedance immunosensor for sub-picogram level detection of bovine interferon gamma based on cylinder-shaped TiO2 nanorods
CN114295694B (zh) 一种用于乳腺癌her-2检测的电化学发光适体传感器及其检测方法
Zhou et al. Carbon nanospheres-promoted electrochemical immunoassay coupled with hollow platinum nanolabels for sensitivity enhancement
CN111060573B (zh) CoFe普鲁士蓝类似物修饰电极及其在同时测定多巴胺和5-羟色胺含量中的应用
Liu et al. Detection of exosomes via an electrochemical biosensor based on C60-Au-Tb composite
Li et al. Capacitor-parallel-amplified decoupled photoelectrochemical/electrochromic dual-mode bioassay for sensitive detection of microRNA with high reliability
Zhai et al. Coating silver metal-organic frameworks onto nitrogen-doped porous carbons for the electrochemical sensing of cysteine
Feng et al. A novel strategy for multiplexed immunoassay of tumor markers based on electrochemiluminescence coupled with cyclic voltammetry using graphene-polymer nanotags
Huang et al. A signal amplification strategy based on peptide self-assembly for the identification of amyloid-β oligomer
Wei et al. Self-assembled electroactive MOF–magnetic dispersible aptasensor enables ultrasensitive microcystin-LR detection in eutrophic water
Chandra et al. Fabrication of a porphyrin-based electrochemical biosensor for detection of nitric oxide released by cancer cells
Si et al. Sensitive electrochemical detection of A549 exosomes based on DNA/ferrocene-modified single-walled carbon nanotube complex
Zhang et al. Electrochemical biosensors for the non-invasive diagnosis of breast cancer
Deng et al. A novel conductive nanocomposite-based biosensor for ultrasensitive detection of microRNA-21 in serum, using methylene blue as mediator
CN113376240A (zh) 基于CeMOF标记的DNA适配体构建的织物基微流控芯片检测Pb2+的方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200602

CF01 Termination of patent right due to non-payment of annual fee